Michael F. Price’s Positive Physicians Holdings, Inc. Common Stock PPHI Stock Holding History

Michael F. Price’s Portfolio PPHI Stock Details PPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$10K	Hold	900	–	–	﹤0.01%	122
2021 Q4	$12K	Hold	900	–	–	﹤0.01%	140
2021 Q3	$8K	Hold	900	–	–	﹤0.01%	142
2021 Q2	$10K	Hold	900	–	–	﹤0.01%	141
2021 Q1	$10K	Hold	900	–	–	﹤0.01%	135
2020 Q4	$8K	Hold	900	–	–	﹤0.01%	115
2020 Q3	$10K	Hold	900	–	–	﹤0.01%	114
2020 Q2	$10K	Hold	900	–	–	﹤0.01%	106
2020 Q1	$10K	Hold	900	–	–	﹤0.01%	106
2019 Q4	$10K	Hold	900	–	–	﹤0.01%	110
2019 Q3	$10K	Hold	900	–	–	﹤0.01%	121
2019 Q2	$12K	Buy	+900	New	+$11.4K	﹤0.01%	112

Other funds holding PPHI

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Michael F. Price's PPHI Position: Q1 2022 in Review

Michael F. Price held its Positive Physicians Holdings, Inc. Common Stock (PPHI) position steady in Q1 2022 at 900 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #122.

Michael F. Price first reported a position in PPHI in Q2 2019 and has held it in 12 quarters since. The position peaked at $12K in Q4 2021. 2 funds tracked by Wall St. Rank hold PPHI as of Q1 2022.

Michael F. Price held 900 shares of Positive Physicians Holdings, Inc. Common Stock worth $10K as of Q1 2022.
Michael F. Price left its Positive Physicians Holdings, Inc. Common Stock share count unchanged in Q1 2022.
Positive Physicians Holdings, Inc. Common Stock made up ﹤0.01% of Michael F. Price's portfolio in Q1 2022, its #122 holding.
Michael F. Price first reported a position in Positive Physicians Holdings, Inc. Common Stock in Q2 2019 and has held it in 12 quarters since.
Michael F. Price's Positive Physicians Holdings, Inc. Common Stock position peaked at $12K in Q4 2021.
2 funds tracked by Wall St. Rank held Positive Physicians Holdings, Inc. Common Stock as of Q1 2022.

Based on Michael F. Price's 13F filing for Q1 2022, filed 16 May 2022.